Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

TLR1/2 orchestrate human plasmacytoid predendritic cell response to gram+ bacteria.

Raieli S, Trichot C, Korniotis S, Pattarini L, Soumelis V.

PLoS Biol. 2019 Apr 24;17(4):e3000209. doi: 10.1371/journal.pbio.3000209. eCollection 2019 Apr.

2.

Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma.

Kerdidani D, Chouvardas P, Arjo AR, Giopanou I, Ntaliarda G, Guo YA, Tsikitis M, Kazamias G, Potaris K, Stathopoulos GT, Zakynthinos S, Kalomenidis I, Soumelis V, Kollias G, Tsoumakidou M.

Nat Commun. 2019 Mar 29;10(1):1405. doi: 10.1038/s41467-019-09370-z.

3.

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.

Lucas N, Duchmann M, Rameau P, Noël F, Michea P, Saada V, Kosmider O, Pierron G, Fernandez-Zapico ME, Howard MT, King RL, Niyongere S, Diop MK, Fenaux P, Itzykson R, Willekens C, Ribrag V, Fontenay M, Padron E, Soumelis V, Droin N, Patnaik MM, Solary E.

Leukemia. 2019 Mar 20. doi: 10.1038/s41375-019-0447-3. [Epub ahead of print]

PMID:
30894665
4.

Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective 'proof of concept' phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)†.

Ghesquieres H, Chevrier M, Laadhari M, Chinot O, Choquet S, Moluçon-Chabrot C, Beauchesne P, Gressin R, Morschhauser F, Schmitt A, Gyan E, Hoang-Xuan K, Nicolas-Virelizier E, Cassoux N, Touitou V, Le Garff-Tavernier M, Savignoni A, Turbiez I, Soumelis V, Houillier C, Soussain C.

Ann Oncol. 2019 Apr 1;30(4):621-628. doi: 10.1093/annonc/mdz032.

PMID:
30698644
5.

Dissecting Effects of Anti-cancer Drugs and Cancer-Associated Fibroblasts by On-Chip Reconstitution of Immunocompetent Tumor Microenvironments.

Nguyen M, De Ninno A, Mencattini A, Mermet-Meillon F, Fornabaio G, Evans SS, Cossutta M, Khira Y, Han W, Sirven P, Pelon F, Di Giuseppe D, Bertani FR, Gerardino A, Yamada A, Descroix S, Soumelis V, Mechta-Grigoriou F, Zalcman G, Camonis J, Martinelli E, Businaro L, Parrini MC.

Cell Rep. 2018 Dec 26;25(13):3884-3893.e3. doi: 10.1016/j.celrep.2018.12.015.

6.

EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription.

Torrino S, Shen WW, Blouin CM, Mani SK, Viaris de Lesegno C, Bost P, Grassart A, Köster D, Valades-Cruz CA, Chambon V, Johannes L, Pierobon P, Soumelis V, Coirault C, Vassilopoulos S, Lamaze C.

J Cell Biol. 2018 Dec 3;217(12):4092-4105. doi: 10.1083/jcb.201801122. Epub 2018 Oct 22.

7.

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts.

Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G.

Oncoimmunology. 2018 Aug 6;7(10):e1484980. doi: 10.1080/2162402X.2018.1484980. eCollection 2018.

8.

Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific.

Michea P, Noël F, Zakine E, Czerwinska U, Sirven P, Abouzid O, Goudot C, Scholer-Dahirel A, Vincent-Salomon A, Reyal F, Amigorena S, Guillot-Delost M, Segura E, Soumelis V.

Nat Immunol. 2018 Aug;19(8):885-897. doi: 10.1038/s41590-018-0145-8. Epub 2018 Jul 16.

PMID:
30013147
9.

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.

Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, Bonneau C, Kondratova M, Kuperstein I, Zinovyev A, Givel AM, Parrini MC, Soumelis V, Vincent-Salomon A, Mechta-Grigoriou F.

Cancer Cell. 2018 Mar 12;33(3):463-479.e10. doi: 10.1016/j.ccell.2018.01.011. Epub 2018 Feb 15.

10.

Plasmacytoid pre-dendritic cells (pDC): from molecular pathways to function and disease association.

Alculumbre S, Raieli S, Hoffmann C, Chelbi R, Danlos FX, Soumelis V.

Semin Cell Dev Biol. 2019 Feb;86:24-35. doi: 10.1016/j.semcdb.2018.02.014. Epub 2018 Feb 19. Review.

PMID:
29444460
11.

A model for the integration of conflicting exogenous and endogenous signals by dendritic cells.

Marcou Q, Carmi-Levy I, Trichot C, Soumelis V, Mora T, Walczak AM.

Phys Biol. 2018 May 16;15(5):056001. doi: 10.1088/1478-3975/aaaa0a.

PMID:
29360100
12.

Thymic stromal lymphopoietin does not activate human basophils.

Salabert-Le Guen N, Hémont C, Delbove A, Poli C, Braudeau C, Fantou A, Amouriaux K, Bériou G, Martin JC, Colas L, Soumelis V, Josien R.

J Allergy Clin Immunol. 2018 Apr;141(4):1476-1479.e6. doi: 10.1016/j.jaci.2017.11.012. Epub 2017 Dec 5. No abstract available.

PMID:
29208546
13.

Diversification of human plasmacytoid predendritic cells in response to a single stimulus.

Alculumbre SG, Saint-André V, Di Domizio J, Vargas P, Sirven P, Bost P, Maurin M, Maiuri P, Wery M, Roman MS, Savey L, Touzot M, Terrier B, Saadoun D, Conrad C, Gilliet M, Morillon A, Soumelis V.

Nat Immunol. 2018 Jan;19(1):63-75. doi: 10.1038/s41590-017-0012-z. Epub 2017 Dec 4.

PMID:
29203862
14.

The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.

Thierry S, Jdey W, Alculumbre S, Soumelis V, Noguiez-Hellin P, Dutreix M.

Mol Cancer Ther. 2017 Dec;16(12):2817-2827. doi: 10.1158/1535-7163.MCT-17-0405. Epub 2017 Sep 25.

15.

Molecular and cellular discoveries in inflammatory dermatoses.

Soumelis V.

J Eur Acad Dermatol Venereol. 2017 Sep;31 Suppl 5:3-7. doi: 10.1111/jdv.14373. Review.

PMID:
28805939
16.

TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand.

Pattarini L, Trichot C, Bogiatzi S, Grandclaudon M, Meller S, Keuylian Z, Durand M, Volpe E, Madonna S, Cavani A, Chiricozzi A, Romanelli M, Hori T, Hovnanian A, Homey B, Soumelis V.

J Exp Med. 2017 May 1;214(5):1529-1546. doi: 10.1084/jem.20150402. Epub 2017 Apr 20.

17.

Of Human DC Migrants and Residents.

Segura E, Soumelis V.

Immunity. 2017 Mar 21;46(3):342-344. doi: 10.1016/j.immuni.2017.03.006.

18.

Keeping skin inflammation local.

Pattarini L, Soumelis V.

Nat Immunol. 2017 Feb 15;18(3):250-251. doi: 10.1038/ni.3687. No abstract available.

PMID:
28198829
19.

[The "immune checkpoints", how does it work].

Granier C, Soumelis V, Mandavit M, Gibault L, Belazzoug R, de Guillebon E, Badoual C, Tartour E, Roussel H.

Ann Pathol. 2017 Feb;37(1):18-28. doi: 10.1016/j.annpat.2016.12.007. Epub 2017 Feb 1. French.

PMID:
28160999
20.

No evidence for TSLP pathway activity in human breast cancer.

Ghirelli C, Sadacca B, Reyal F, Zollinger R, Michea P, Sirven P, Pattarini L, Martínez-Cingolani C, Guillot-Delost M, Nicolas A, Scholer-Dahirel A, Soumelis V.

Oncoimmunology. 2016 May 9;5(8):e1178438. doi: 10.1080/2162402X.2016.1178438. eCollection 2016 Aug.

21.

Ligand-receptor dissociated expression explains high TSLP without prognostic impact in human primary head and neck squamous cell carcinoma.

Guillot-Delost M, Guilleré L, Berger F, Ventre A, Michea P, Sirven P, Pattarini L, Scholer-Dahirel A, Kebir FZ, Huerre M, Chouchane-Mlik O, Lappartient E, Rodriguez J, Jouffroy T, Klijanienko J, Nicolas A, Sastre-Garau X, Honorio S, Mosseri V, Le Peltier N, Sablin MP, Le Tourneau C, Tartour É, Badoual C, Soumelis V.

Oncoimmunology. 2016 Jun 7;5(7):e1179414. doi: 10.1080/2162402X.2016.1179414. eCollection 2016 Jul.

22.

Using Transcriptional Signatures to Assess Immune Cell Function: From Basic Mechanisms to Immune-Related Disease.

Touzot M, Dahirel A, Cappuccio A, Segura E, Hupé P, Soumelis V.

J Mol Biol. 2015 Oct 23;427(21):3356-67. doi: 10.1016/j.jmb.2015.05.006. Epub 2015 May 15. Review.

PMID:
25986308
23.

Breast Cancer Cell-Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes.

Ghirelli C, Reyal F, Jeanmougin M, Zollinger R, Sirven P, Michea P, Caux C, Bendriss-Vermare N, Donnadieu MH, Caly M, Fourchotte V, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X, Soumelis V.

Cancer Res. 2015 Jul 15;75(14):2775-87. doi: 10.1158/0008-5472.CAN-14-2386. Epub 2015 May 14.

24.

Combinatorial code governing cellular responses to complex stimuli.

Cappuccio A, Zollinger R, Schenk M, Walczak A, Servant N, Barillot E, Hupé P, Modlin RL, Soumelis V.

Nat Commun. 2015 Apr 21;6:6847. doi: 10.1038/ncomms7847.

25.

Model checking to assess T-helper cell plasticity.

Abou-Jaoudé W, Monteiro PT, Naldi A, Grandclaudon M, Soumelis V, Chaouiya C, Thieffry D.

Front Bioeng Biotechnol. 2015 Jan 28;2:86. doi: 10.3389/fbioe.2014.00086. eCollection 2014.

26.

Systems approaches to unravel innate immune cell diversity, environmental plasticity and functional specialization.

Soumelis V, Pattarini L, Michea P, Cappuccio A.

Curr Opin Immunol. 2015 Feb;32:42-7. doi: 10.1016/j.coi.2014.12.007. Epub 2015 Jan 10. Review.

PMID:
25588554
27.

IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.

Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D.

Autoimmun Rev. 2015 May;14(5):370-5. doi: 10.1016/j.autrev.2014.12.009. Epub 2014 Dec 23. Review.

PMID:
25541082
28.

Human blood BDCA-1 dendritic cells differentiate into Langerhans-like cells with thymic stromal lymphopoietin and TGF-β.

Martínez-Cingolani C, Grandclaudon M, Jeanmougin M, Jouve M, Zollinger R, Soumelis V.

Blood. 2014 Oct 9;124(15):2411-20. doi: 10.1182/blood-2014-04-568311. Epub 2014 Aug 11.

29.

IFNL3 expression and response to treatment: behind the HCV tricks.

Alculumbre S, Estrabaud E, Soumelis V, Asselah T.

J Hepatol. 2014 Oct;61(4):944-6. doi: 10.1016/j.jhep.2014.06.002. Epub 2014 Jun 11. No abstract available.

30.

Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis.

Volpe E, Pattarini L, Martinez-Cingolani C, Meller S, Donnadieu MH, Bogiatzi SI, Fernandez MI, Touzot M, Bichet JC, Reyal F, Paronetto MP, Chiricozzi A, Chimenti S, Nasorri F, Cavani A, Kislat A, Homey B, Soumelis V.

J Allergy Clin Immunol. 2014 Aug;134(2):373-81. doi: 10.1016/j.jaci.2014.04.022. Epub 2014 Jun 6.

PMID:
24910175
31.

Combinatorial flexibility of cytokine function during human T helper cell differentiation.

Touzot M, Grandclaudon M, Cappuccio A, Satoh T, Martinez-Cingolani C, Servant N, Manel N, Soumelis V.

Nat Commun. 2014 May 28;5:3987. doi: 10.1038/ncomms4987.

PMID:
24865484
32.

A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.

Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, Soumelis V, Feld M, Alenius H, Dillon SR, Carstens E, Homey B, Basbaum A, Steinhoff M.

J Allergy Clin Immunol. 2014 Feb;133(2):448-60. doi: 10.1016/j.jaci.2013.10.048. Epub 2013 Dec 25.

33.

Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade.

Leyva-Castillo JM, Hener P, Michea P, Karasuyama H, Chan S, Soumelis V, Li M.

Nat Commun. 2013;4:2847. doi: 10.1038/ncomms3847.

PMID:
24284909
34.

Epithelial control of the human pDC response to extracellular bacteria.

Michea P, Vargas P, Donnadieu MH, Rosemblatt M, Bono MR, Duménil G, Soumelis V.

Eur J Immunol. 2013 May;43(5):1264-73. doi: 10.1002/eji.201242990. Epub 2013 Mar 6.

35.

Human inflammatory dendritic cells induce Th17 cell differentiation.

Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, Dalod M, Soumelis V, Amigorena S.

Immunity. 2013 Feb 21;38(2):336-48. doi: 10.1016/j.immuni.2012.10.018. Epub 2013 Jan 24.

36.

HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.

Florentin J, Aouar B, Dental C, Thumann C, Firaguay G, Gondois-Rey F, Soumelis V, Baumert TF, Nunès JA, Olive D, Hirsch I, Stranska R.

Blood. 2012 Nov 29;120(23):4544-51. doi: 10.1182/blood-2012-02-413286. Epub 2012 Oct 10.

37.

Multiple-checkpoint inhibition of thymic stromal lymphopoietin-induced TH2 response by TH17-related cytokines.

Bogiatzi SI, Guillot-Delost M, Cappuccio A, Bichet JC, Chouchane-Mlik O, Donnadieu MH, Barillot E, Hupé P, Chlichlia K, Efremidou EI, Aractingi S, Bayrou O, Soumelis V.

J Allergy Clin Immunol. 2012 Jul;130(1):233-40.e5. doi: 10.1016/j.jaci.2012.04.038. Epub 2012 Jun 2.

PMID:
22664159
38.

Characterization of resident and migratory dendritic cells in human lymph nodes.

Segura E, Valladeau-Guilemond J, Donnadieu MH, Sastre-Garau X, Soumelis V, Amigorena S.

J Exp Med. 2012 Apr 9;209(4):653-60. doi: 10.1084/jem.20111457. Epub 2012 Mar 19.

39.

TSLP: from allergy to vaccine adjuvant.

Soumelis V.

Eur J Immunol. 2012 Feb;42(2):293-5. doi: 10.1002/eji.201142337.

40.

NRP-1 and IL-17-producing NKT cells.

Soumelis V.

Blood. 2011 Sep 15;118(11):2934-5. doi: 10.1182/blood-2011-07-361279. No abstract available.

41.

A dive into the complexity of type I interferon antiviral functions.

Touzot M, Soumelis V, Asselah T.

J Hepatol. 2012 Mar;56(3):726-8. doi: 10.1016/j.jhep.2011.07.009. Epub 2011 Jul 27. No abstract available.

42.

The human cytokine TSLP triggers a cell-autonomous dendritic cell migration in confined environments.

Fernandez MI, Heuzé ML, Martinez-Cingolani C, Volpe E, Donnadieu MH, Piel M, Homey B, Lennon-Duménil AM, Soumelis V.

Blood. 2011 Oct 6;118(14):3862-9. doi: 10.1182/blood-2010-12-323089. Epub 2011 Jul 19.

43.

Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V, Klatzmann D, Cacoub P, Saadoun D.

J Allergy Clin Immunol. 2011 Sep;128(3):655-64. doi: 10.1016/j.jaci.2011.05.029. Epub 2011 Jul 2.

PMID:
21724243
44.

A modular view of cytokine networks in atopic dermatitis.

Carmi-Levy I, Homey B, Soumelis V.

Clin Rev Allergy Immunol. 2011 Dec;41(3):245-53. doi: 10.1007/s12016-010-8239-6. Review.

PMID:
21222175
45.

An inhibitor of cyclin-dependent kinases suppresses TLR signaling and increases the susceptibility of cancer patients to herpesviridae.

Zoubir M, Flament C, Gdoura A, Bahleda R, Litvinova E, Soumelis V, Conforti R, Viaud S, Soria JC, Kroemer G, Zitvogel L, Chaput N.

Cell Cycle. 2011 Jan 1;10(1):118-26. Epub 2011 Jan 1.

PMID:
21200142
46.

DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells.

Cavalieri D, Rivero D, Beltrame L, Buschow SI, Calura E, Rizzetto L, Gessani S, Gauzzi MC, Reith W, Baur A, Bonaiuti R, Brandizi M, De Filippo C, D'Oro U, Draghici S, Dunand-Sauthier I, Gatti E, Granucci F, Gündel M, Kramer M, Kuka M, Lanyi A, Melief CJ, van Montfoort N, Ostuni R, Pierre P, Popovici R, Rajnavolgyi E, Schierer S, Schuler G, Soumelis V, Splendiani A, Stefanini I, Torcia MG, Zanoni I, Zollinger R, Figdor CG, Austyn JM.

Immunome Res. 2010 Nov 19;6:10. doi: 10.1186/1745-7580-6-10.

47.

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

Asselah T, Estrabaud E, Bieche I, Lapalus M, De Muynck S, Vidaud M, Saadoun D, Soumelis V, Marcellin P.

Liver Int. 2010 Oct;30(9):1259-69. doi: 10.1111/j.1478-3231.2010.02283.x. Review.

48.

Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs).

Lepelletier Y, Zollinger R, Ghirelli C, Raynaud F, Hadj-Slimane R, Cappuccio A, Hermine O, Liu YJ, Soumelis V.

Blood. 2010 Nov 4;116(18):3389-97. doi: 10.1182/blood-2010-05-282913. Epub 2010 Jun 30.

49.

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.

Guiducci C, Gong M, Xu Z, Gill M, Chaussabel D, Meeker T, Chan JH, Wright T, Punaro M, Bolland S, Soumelis V, Banchereau J, Coffman RL, Pascual V, Barrat FJ.

Nature. 2010 Jun 17;465(7300):937-41. doi: 10.1038/nature09102.

50.

Injury to the stratum corneum induces in vivo expression of human thymic stromal lymphopoietin in the epidermis.

Angelova-Fischer I, Fernandez IM, Donnadieu MH, Bulfone-Paus S, Zillikens D, Fischer TW, Soumelis V.

J Invest Dermatol. 2010 Oct;130(10):2505-7. doi: 10.1038/jid.2010.143. Epub 2010 Jun 17. No abstract available.

Supplemental Content

Loading ...
Support Center